Efficacy of methotrexate, doxorubicin, and cisplatin for osteosarcoma-Reference-Cited by-同舟云学术

Efficacy of methotrexate, doxorubicin, and cisplatin for osteosarcoma

Published:2019-02 Issue:6 Volume:98 Page:e14442
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Tang Qing-xi,Wang Lu-Chuan,Wang Yu,Gao Hong-da,Hou Zhi-ling

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference22 articles.

1. Progress in the chemotherapeutic treatment of osteosarcoma;Zhang;Oncol Lett,2018

2. Systematic meta-analysis of genetic variants associated with osteosarcoma susceptibility;Wang;Medicine (Baltimore),2018

3. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide;Bacci;Oncol Rep,2000

4. Extracellular vesicles-mediated signaling in the osteosarcoma microenvironment: roles and potential therapeutic targets;Lan;J Bone Oncol,2018

5. Tumor syndromes predisposing to osteosarcoma;Hameed;Adv Anat Pathol,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNAs as the pivotal regulators of cisplatin resistance in osteosarcoma;Pathology - Research and Practice;2023-09

2. MicroRNA34a is associated with chemotherapy resistance, metastasis, recurrence, survival, and prognosis in patient with osteosarcoma;Medicine;2022-09-23

3. A Study of Glutathione-Responsive Dual-Drug-Loaded Nanoparticles in Anti-Osteosarcoma Treatment;Journal of Biomedical Nanotechnology;2022-08-01

4. Suppression of Estrogen Receptor Alpha Inhibits Cell Proliferation, Differentiation and Enhances the Chemosensitivity of P53-Positive U2OS Osteosarcoma Cell;International Journal of Molecular Sciences;2021-10-18

5. Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors;Frontiers in Pharmacology;2021-09-09